$7.34
0.65[9.72%]
At close: Apr 26
$7.34
0[0.00%]
After Hours: 5:19PM EDT
Pulse Biosciences
(NASDAQ:PLSE)Latest News for Pulse Biosciences Stock (NASDAQ:PLSE)
Pulse Biosciences Stock (NASDAQ: PLSE)
Categories: All
Monday, April 01, 2024
- Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Apr 1, 2024, 2:31PM
- Pulse Biosciences shares are trading lower after the company last week reported Q4 financial results. Also, the company announced plans to initiate a rights offering of up to $60 million worth of units.Benzinga Newsdesk - Apr 1, 2024, 1:24PM
- Oxford Industries, PVH And 3 Stocks To Watch Heading Into MondayAvi Kapoor - Apr 1, 2024, 3:33AM
Friday, March 29, 2024
Thursday, March 28, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Mar 28, 2024, 4:31PM
- Pulse Biosciences shares are trading lower after the company reported Q4 financial results. Also, the company announced plans to initiate a rights offering of up to $60 million worth of units.Benzinga Newsdesk - Mar 28, 2024, 4:30PM
- Pulse Biosciences Q4 EPS $(0.22) Up From $(0.25) YoYBenzinga Newsdesk - Mar 28, 2024, 4:29PM
- Pulse Biosciences Board Unanimously Approves Plan To Initiate Rights Offering Of Up To $60M Worth Of UnitsBenzinga Newsdesk - Mar 28, 2024, 4:11PM
- Earnings Scheduled For March 28, 2024Benzinga Insights - Mar 28, 2024, 5:24AM
Monday, March 11, 2024
Friday, March 08, 2024
Wednesday, February 14, 2024
Wednesday, January 31, 2024
Tuesday, January 02, 2024
Wednesday, December 20, 2023
Tuesday, December 19, 2023
Wednesday, December 13, 2023
Thursday, December 07, 2023
Monday, December 04, 2023
Monday, November 27, 2023
- Pulse Biosciences shares are trading higher after the company said it has received all regulatory approvals and it has substantially completed all required activities to commence its planned catheter ablation feasibility study. The company also said Executive Chairman, Robert W. Duggan, has informed management that he is evaluating one or more potential market purchases of Company common stock.Benzinga Newsdesk - Nov 27, 2023, 2:55PM
- Pulse Biosciences Says As Of Today, Co. Has Received All Regulatory Approvals And Has Substantially Completed All Required Activities To Commence Its Planned Catheter Ablation Feasibility Study. First Study Procedures Scheduled For Mid-December 2023Benzinga Newsdesk - Nov 27, 2023, 9:21AM
Tuesday, November 21, 2023
- Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On TuesdayLisa Levin - Nov 21, 2023, 11:42AM
- Pulse Biosciences Director Trades $123K In Company StockBenzinga Insights - Nov 21, 2023, 10:02AM
- Pulse Biosciences Files 510(k) Submission With US FDA For Its CellFX nsPFA Percutaneous ElectrodeBenzinga Newsdesk - Nov 21, 2023, 8:04AM
Thursday, November 16, 2023
Monday, November 13, 2023
Friday, November 10, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Wednesday, August 30, 2023
Tuesday, August 29, 2023
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Aug 29, 2023, 1:31PM
- Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Aug 29, 2023, 12:51PM
- Pulse Biosciences Board Member Acquires 1,667 Shares After Exercising Company Stock OptionsBenzinga Insights - Aug 29, 2023, 11:00AM
Monday, August 28, 2023
Thursday, August 10, 2023
Monday, July 31, 2023
Friday, July 28, 2023
Thursday, July 27, 2023
Wednesday, June 07, 2023
- Director at Pulse Biosciences Acquires Company Stock Options Worth 48,487 SharesBenzinga Insights - Jun 7, 2023, 11:01AM
- Pulse Biosciences Board Member Awarded $259K Worth of Stock OptionsBenzinga Insights - Jun 7, 2023, 11:01AM
- Pulse Biosciences Director Awarded $129K Worth of Stock OptionsBenzinga Insights - Jun 7, 2023, 11:00AM
- Pulse Biosciences Board Member Awarded $129K Worth of Stock OptionsBenzinga Insights - Jun 7, 2023, 11:00AM
- Director at Pulse Biosciences Acquires Company Stock Options Worth 59,731 SharesBenzinga Insights - Jun 7, 2023, 11:00AM